ABSLAMC.NS(ABSLAMC.NS)
ABSLAMC.NS
No analyst ratings available
No analyst price targets available for ABSLAMC.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $20.43B | $23.33B | $26.50B | $33.13B | $37.74B |
| Low | $19.81B | $22.81B | $26.01B | $32.32B | $36.82B |
| High | $20.72B | $23.80B | $27.76B | $33.93B | $38.65B |
| EBITDA Avg | $14.63B | $16.71B | $18.98B | $23.73B | $27.03B |
| Low | $14.19B | $16.34B | $18.63B | $23.15B | $26.37B |
| High | $14.84B | $17.05B | $19.89B | $24.30B | $27.68B |
| EBIT Avg | $14.12B | $16.12B | $18.31B | $22.89B | $26.07B |
| Low | $13.69B | $15.76B | $17.97B | $22.33B | $25.43B |
| High | $14.31B | $16.45B | $19.18B | $23.44B | $26.70B |
| Net Income Avg | $11.18B | $12.87B | $14.19B | $17.46B | $19.74B |
| Low | $10.95B | $12.56B | $13.36B | $16.90B | $19.12B |
| High | $12.09B | $13.17B | $15.36B | $18.00B | $20.36B |
| EPS Avg | $38.60 | $43.60 | $50.02 | $60.30 | $68.20 |
| Low | $37.81 | $43.40 | $46.16 | $58.39 | $66.04 |
| High | $41.76 | $45.50 | $53.07 | $62.19 | $70.34 |
| Analysts (Rev / EPS) | 5 / 10 | 5 / 10 | 4 / 6 | 3 / 2 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $4.84B | $5.13B | $5.24B |
| Low | $4.84B | $5.13B | $5.24B |
| High | $4.84B | $5.13B | $5.24B |
| EBITDA Avg | $3.47B | $3.67B | $3.75B |
| Low | $3.47B | $3.67B | $3.75B |
| High | $3.47B | $3.67B | $3.75B |
| EBIT Avg | $3.34B | $3.54B | $3.62B |
| Low | $3.34B | $3.54B | $3.62B |
| High | $3.34B | $3.54B | $3.62B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |